Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study has found. UCSF researchers are the first to demonstrate that the approach works for the ...
While medical breakthroughs have made ending HIV transmission a realistic goal, experts warn that stigma and misinformation ...
Long-term HIV survivors showed willingness to participate in EOL research, valuing autonomy and ethical safeguards. Participants emphasized the need for clear communication of study risks and purposes ...
Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study by researchers at UC San Francisco has found. The strategy could also help stop the spread ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results